课题基金 / 基金详情

HEME ARGINATE IN ACUTE PORPHYRIA

HEME ARGINATE IN ACUTE PORPHYRIA
精氨酸血红素治疗急性卟啉症
批准号:
6246315
负责人:
KARL E ANDERSON
金额:
$2.71万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-01-06 至 1997-11-30

项目摘要

项目成果

KARL E ANDERSON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Purpose to determine the efficacy and safety of heme arginate for the treatment of the acute porphyrias. Specific aims are 1) to determine in 20 patients with acute attacks of porphyria whether heme arginate is safe and effective in producing remissions of symptoms and lowering porphyrin precursors; 2) doseranging studies of effects of heme arginate on reducing porphyrin precursor levels in 16 stable patients with acute intermittent porphyria; and 3) to study the value of heme arginate infusions for prevention of attacks of porphyria in 15 patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CHARACTERIZATION OF ENZYME DEFECTS IN PORPHYRIAS
STUDIES IN PORPHYRIA III, HEME, AND TIN MESOPORPHYRIN IN ACUTE PORPHYRIAS
HEME ARGINATE IN ACUTE PORPHYRIA
STUDIES IN PORPHYRIA CUTANEA TARDA
海外基金